Empowering genomic breakthroughs
Faster, safer and smarter tools accelerate scientific discovery. As of June 2025, a new initiative, SynHG (synthetic Human Genome), aims to develop scalable tools and technologies for synthesising human genomes. This five-year research project marks a bold step forward in genomics.
How to use AI responsibly
In regulated industries, the promise of AI is huge – faster decisions, deeper insights, greater efficiency. But so are the risks. Mission-critical applications demand more than cutting-edge algorithms or powerful models. They require responsible intelligence. AI that is auditable, explainable and aligned with regulatory standards from day one. That’s only possible when human expertise and AI innovation are brought together by design, not as an afterthought.
Comment: Antibiotic availability
A new independent study, sponsored by healthcare company Viatris, Securing access, improving lives. Strengthening patients’ access to off-patent medicines in Europe, investigates the reasons behind the increasing unavailability of medicines, focusing on antibiotics.